受体相互作用蛋白激酶-3决定了细胞对TNF-α的死亡反应
1Graduate Program, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Cell
|June 16, 2009
概括
受体相互作用蛋白激酶3 (RIPK3) 对于缩至关重要,这是由瘤缩因子-α (TNF-α) 触发的细胞死亡途径. RIPK3的激活会导致诱导亡的复合体,防止炎症和组织损伤.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 斯马克模拟剂和TNF-α通过含有RIPK1的复合体协同诱导亡.
- 酶抑制剂可以阻断细胞亡,但在某些细胞系中促进亡.
研究的目的:
- 为了确定分子参与者,确定细胞亡和亡之间的切换.
- 阐明 RIP 激酶家族成员在 TNF-α 诱导的细胞死亡中的作用.
主要方法:
- 全基因组siRNA屏幕用于识别调节死的基因.
- 在各种细胞系中分析RIPK3表达和激酶活性.
- 在RIPK3淘汰赛小鼠胚胎纤维细胞和动物中对亡的评估.
主要成果:
- 确定RIPK3对于诱导亡至关重要.
- RIPK3表达水平与死反应相关.
- 对RIPK3酶的活性及其对RIPK1的招募对于缩至关重要.
- 在急性胰腺炎模型中,RIPK3淘汰小鼠显示出对亡的抵抗力和减少炎症.
结论:
- RIPK3是对TNF-α家族细胞因子的反应中死亡的关键决定因素.
- 准RIPK3可能为炎症性疾病提供治疗策略.
相关概念视频
NF-κB-dependent Signaling Pathway
7.6K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.6K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Regulation of the Unfolded Protein Response
2.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
Necrosis
5.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K


